speb/financial-data huggingface dataset:
BODI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5748000.00
BODI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — Net Interest Income: -1565000.00
BODI cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -3625000.00
BODI cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -3625000.00
BODI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1565000.00
BODI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -151000.00
BODI balance_sheet (quarterly, 2025-03-31) — Net PPE: 13465000.00
BODI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -694000.00
BODI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -41131000.00
BODI balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 10138000.00
BODI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 0.00
BODI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
BODI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2168000.00
BODI income_statement (quarterly, 2025-03-31) — Normalized Income: -5203690.00
BODI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2342000.00
BODI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 689000.00
BODI income_statement (quarterly, 2025-03-31) — Operating Income: -3674000.00
BODI income_statement (quarterly, 2025-03-31) — Operating Revenue: 72363000.00
BODI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 6988364.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1544000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 16425000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 3502000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -58000.00
BODI income_statement (quarterly, 2025-03-31) — Other Gand A: 11657000.00
BODI income_statement (quarterly, 2025-03-31) — Other Income Expense: -464000.00
BODI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1141000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2112000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 7985000.00
BODI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 225000.00
BODI balance_sheet (quarterly, 2025-03-31) — Other Properties: 2804000.00
BODI balance_sheet (quarterly, 2025-03-31) — Payables: 11189000.00
BODI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 23155000.00
BODI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4591000.00
BODI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BODI balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 7362000.00
BODI income_statement (quarterly, 2025-03-31) — Pretax Income: -5703000.00
BODI cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 47000.00
BODI balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BODI cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 146000.00
BODI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -694000.00
BODI balance_sheet (quarterly, 2025-03-31) — Raw Materials: 6421000.00
BODI balance_sheet (quarterly, 2025-03-31) — Receivables: 1933000.00
BODI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 20814000.00
BODI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5617000.00
BODI cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3625000.00
BODI income_statement (quarterly, 2025-03-31) — Research And Development: 12596000.00
BODI balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4350000.00
BODI income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
BODI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -649266000.00
BODI cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 30970000.00
BODI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 42627000.00
BODI balance_sheet (quarterly, 2025-03-31) — Share Issued: 6988364.00
BODI income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BODI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1726000.00
BODI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 24035000.00
BODI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -41131000.00
BODI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -144690.00
BODI income_statement (quarterly, 2025-03-31) — Tax Provision: 45000.00
BODI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BODI balance_sheet (quarterly, 2025-03-31) — Total Assets: 152539000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 24035000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Debt: 19452000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 24035000.00
BODI income_statement (quarterly, 2025-03-31) — Total Expenses: 76037000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 128504000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 90881000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9660000.00
BODI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3674000.00
BODI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 3016000.00
BODI income_statement (quarterly, 2025-03-31) — Total Unusual Items: -689000.00
BODI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -689000.00
BODI balance_sheet (quarterly, 2025-03-31) — Working Capital: -57186000.00
BODI income_statement (quarterly, 2025-06-30) — +Operating Expense: 47710000.00
BODI income_statement (quarterly, 2025-06-30) — +Total Revenue: 63941000.00
BODI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4970000.00
BODI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1851000.00
BODI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -127690000.00
BODI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 675386000.00
BODI cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 2289000.00
BODI cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 2289000.00
BODI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 6951000.00
BODI income_statement (quarterly, 2025-06-30) — Basic EPS: -0.85
BODI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 18126000.00
BODI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1817000.00
BODI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2730000.00
BODI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
BODI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 25461000.00
BODI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 25461000.00
BODI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4514000.00
BODI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1817000.00
BODI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 4238000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3337000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 691000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1663000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 6910000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1345000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -4991000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Payable: -3337000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2646000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 2481000.00
BODI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2072000.00
BODI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 6935000.00
BODI balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
BODI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 20158000.00
BODI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 17703000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 11975000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Assets: 57295000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1361000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1361000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 8248000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 66640000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 66640000.00
BODI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 96134000.00
BODI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
BODI cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
BODI cash_flow (quarterly, 2025-06-30) — Depreciation: 2022000.00
BODI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4311000.00
BODI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4311000.00
BODI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 6951000.00
BODI income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.85
BODI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — EBIT: -4531000.00
BODI income_statement (quarterly, 2025-06-30) — EBITDA: -220000.00
BODI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 500000.00
BODI cash_flow (quarterly, 2025-06-30) — End Cash Position: 25561000.00
BODI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4514000.00
BODI balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5639000.00
BODI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2421000.00
BODI cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -1558000.00
BODI cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1558000.00
BODI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -64000.00
BODI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11571000.00
BODI balance_sheet (quarterly, 2025-06-30) — Goodwill: 65166000.00
BODI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 140836000.00
BODI income_statement (quarterly, 2025-06-30) — Gross Profit: 46238000.00
BODI income_statement (quarterly, 2025-06-30) — Interest Expense: 1268000.00
BODI income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1268000.00
BODI cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 255000.00
BODI balance_sheet (quarterly, 2025-06-30) — Inventory: 11406000.00
BODI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 43458000.00
BODI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1817000.00
BODI balance_sheet (quarterly, 2025-06-30) — Leases: 1117000.00
BODI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1369000.00
BODI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 23300000.00
BODI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 24669000.00
BODI cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -18957000.00
BODI balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 137179000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5900000.00
BODI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5900000.00
BODI income_statement (quarterly, 2025-06-30) — Net Interest Income: -1268000.00
BODI cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 6043000.00
BODI cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 6043000.00
BODI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1268000.00
BODI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1607000.00
BODI balance_sheet (quarterly, 2025-06-30) — Net PPE: 13146000.00
BODI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1817000.00
BODI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -45008000.00
BODI balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 8451000.00
BODI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 0.00
BODI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 0.00
BODI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2880000.00
BODI income_statement (quarterly, 2025-06-30) — Normalized Income: -3451000.00
BODI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 4238000.00
BODI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 608000.00
BODI income_statement (quarterly, 2025-06-30) — Operating Income: -1472000.00
BODI income_statement (quarterly, 2025-06-30) — Operating Revenue: 63941000.00
BODI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 7066134.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1292000.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2561000.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -64000.00
BODI income_statement (quarterly, 2025-06-30) — Other Gand A: 11571000.00
BODI income_statement (quarterly, 2025-06-30) — Other Income Expense: -3059000.00
BODI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 719000.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1836000.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4933000.00
BODI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 41000.00
BODI balance_sheet (quarterly, 2025-06-30) — Other Properties: 2540000.00
BODI income_statement (quarterly, 2025-06-30) — Other Special Charges: 2166000.00
BODI balance_sheet (quarterly, 2025-06-30) — Payables: 7729000.00
BODI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 19704000.00
BODI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 5868000.00
BODI balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BODI balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 4687000.00
BODI income_statement (quarterly, 2025-06-30) — Pretax Income: -5799000.00
BODI cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 78000.00
BODI balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
BODI cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 413000.00
BODI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1817000.00
BODI balance_sheet (quarterly, 2025-06-30) — Raw Materials: 5767000.00
BODI balance_sheet (quarterly, 2025-06-30) — Receivables: 1851000.00
BODI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 17703000.00
BODI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4311000.00
BODI cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -18957000.00
BODI income_statement (quarterly, 2025-06-30) — Research And Development: 10611000.00
BODI balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 4350000.00
BODI income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 2492000.00
BODI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -655166000.00
BODI cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 25528000.00
BODI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 37099000.00
BODI balance_sheet (quarterly, 2025-06-30) — Share Issued: 7066134.00
BODI income_statement (quarterly, 2025-06-30) — Special Income Charges: -4658000.00
BODI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2015000.00
BODI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 20158000.00
BODI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -45008000.00
BODI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -651000.00
BODI income_statement (quarterly, 2025-06-30) — Tax Provision: 101000.00
BODI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
BODI balance_sheet (quarterly, 2025-06-30) — Total Assets: 145894000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 43458000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Debt: 26030000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 20158000.00
BODI income_statement (quarterly, 2025-06-30) — Total Expenses: 65413000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 125736000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 88599000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 29602000.00
BODI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3964000.00
BODI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 2759000.00
BODI income_statement (quarterly, 2025-06-30) — Total Unusual Items: -3100000.00
BODI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -3100000.00
BODI balance_sheet (quarterly, 2025-06-30) — Working Capital: -38839000.00
BODI income_statement (quarterly, 2025-09-30) — +Operating Expense: 39675000.00
BODI income_statement (quarterly, 2025-09-30) — +Total Revenue: 59887000.00
BODI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4280000.00
BODI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1454000.00
BODI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -112532000.00
BODI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 676353000.00
BODI cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1927000.00
BODI cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1927000.00
BODI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 6999000.00
BODI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.51
BODI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 25561000.00
BODI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1187000.00
BODI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2029000.00
BODI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
BODI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 33849000.00
BODI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 33849000.00
BODI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -274000.00
BODI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1187000.00
BODI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 10187000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -587000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 3062000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Inventory: -441000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 3877000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1656000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -5074000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Payable: -587000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2475000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 370000.00
BODI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -449000.00
BODI cash_flow (quarterly, 2025-09-30) — Changes In Cash: 8726000.00
BODI balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
BODI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 24690000.00
BODI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 15238000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 14297000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Assets: 60376000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1060000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Debt: 531000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1591000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 3876000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 62250000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 62250000.00
BODI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 93078000.00
BODI cash_flow (quarterly, 2025-09-30) — Depreciation: 1879000.00
BODI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3806000.00
BODI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3806000.00
BODI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7046000.00
BODI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.51
BODI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — EBIT: 4576000.00
BODI income_statement (quarterly, 2025-09-30) — EBITDA: 8382000.00
BODI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -338000.00
BODI cash_flow (quarterly, 2025-09-30) — End Cash Position: 33949000.00
BODI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -274000.00
BODI balance_sheet (quarterly, 2025-09-30) — Finished Goods: 5319000.00
BODI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 9000000.00
BODI cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 762000.00
BODI cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -762000.00
BODI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -68000.00
BODI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10139000.00
BODI balance_sheet (quarterly, 2025-09-30) — Goodwill: 65166000.00
BODI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 124226000.00
BODI income_statement (quarterly, 2025-09-30) — Gross Profit: 44649000.00
BODI income_statement (quarterly, 2025-09-30) — Interest Expense: 1056000.00
BODI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1056000.00
BODI cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 858000.00
BODI balance_sheet (quarterly, 2025-09-30) — Inventory: 11149000.00
BODI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 48150000.00
BODI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1187000.00
BODI cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
BODI balance_sheet (quarterly, 2025-09-30) — Leases: 1117000.00
BODI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 969000.00
BODI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 22929000.00
BODI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 23898000.00
BODI cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
BODI cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
BODI balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 121207000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3569000.00
BODI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3569000.00
BODI income_statement (quarterly, 2025-09-30) — Net Interest Income: -1056000.00
BODI cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
BODI cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
BODI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1056000.00
BODI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -294000.00
BODI balance_sheet (quarterly, 2025-09-30) — Net PPE: 11694000.00
BODI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1187000.00
BODI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -40476000.00
BODI balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 7528000.00
BODI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 9132000.00
BODI income_statement (quarterly, 2025-09-30) — Normalized Income: 4161500.00
BODI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 10187000.00
BODI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 762000.00
BODI income_statement (quarterly, 2025-09-30) — Operating Income: 4974000.00
BODI income_statement (quarterly, 2025-09-30) — Operating Revenue: 59887000.00
BODI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7088037.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1381000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 531000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1604000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -68000.00
BODI income_statement (quarterly, 2025-09-30) — Other Gand A: 10139000.00
BODI income_statement (quarterly, 2025-09-30) — Other Income Expense: -398000.00
BODI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 799000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1648000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4746000.00
BODI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 352000.00
BODI balance_sheet (quarterly, 2025-09-30) — Other Properties: 1902000.00
BODI balance_sheet (quarterly, 2025-09-30) — Payables: 6758000.00
BODI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 21055000.00
BODI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 6578000.00
BODI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BODI balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 4317000.00
BODI income_statement (quarterly, 2025-09-30) — Pretax Income: 3520000.00
BODI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 20000.00
BODI balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
BODI cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 697000.00
BODI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1187000.00
BODI balance_sheet (quarterly, 2025-09-30) — Raw Materials: 5830000.00
BODI balance_sheet (quarterly, 2025-09-30) — Receivables: 1454000.00
BODI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 15238000.00
BODI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3806000.00
BODI cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
BODI income_statement (quarterly, 2025-09-30) — Research And Development: 10406000.00
BODI balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 4350000.00
BODI income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: -12000.00
BODI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -651597000.00
BODI cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 19130000.00
BODI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 29269000.00
BODI balance_sheet (quarterly, 2025-09-30) — Share Issued: 7088037.00
BODI income_statement (quarterly, 2025-09-30) — Special Income Charges: 12000.00
BODI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1003000.00
BODI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 24690000.00
BODI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -40476000.00
BODI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -157500.00
BODI income_statement (quarterly, 2025-09-30) — Tax Provision: -49000.00
BODI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
BODI balance_sheet (quarterly, 2025-09-30) — Total Assets: 146412000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 47619000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Debt: 25489000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 24690000.00
BODI income_statement (quarterly, 2025-09-30) — Total Expenses: 54913000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 121722000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 86036000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28644000.00
BODI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 4986000.00
BODI balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 2478000.00
BODI income_statement (quarterly, 2025-09-30) — Total Unusual Items: -750000.00
BODI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -750000.00
BODI balance_sheet (quarterly, 2025-09-30) — Working Capital: -32702000.00
BODI income_statement (annual, 2025-12-31) — +Operating Expense: 175776000.00
BODI income_statement (quarterly, 2025-12-31) — +Operating Expense: 33168000.00
BODI income_statement (annual, 2025-12-31) — +Total Revenue: 251727000.00
BODI income_statement (quarterly, 2025-12-31) — +Total Revenue: 55536000.00
BODI balance_sheet (annual, 2025-12-31) — Accounts Payable: 5304000.00
BODI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5304000.00
BODI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1138000.00
BODI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1138000.00
BODI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -112059000.00
BODI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -112059000.00
BODI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 677743000.00
BODI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 677743000.00
BODI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 8874000.00
BODI cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1929000.00
BODI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 8874000.00
BODI cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1929000.00
BODI cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
BODI income_statement (annual, 2025-12-31) — Basic Average Shares: 6971000.00
BODI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7051000.00
BODI income_statement (annual, 2025-12-31) — Basic EPS: -0.41
BODI income_statement (quarterly, 2025-12-31) — Basic EPS: 0.74
BODI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 20187000.00
BODI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 33949000.00
BODI cash_flow (annual, 2025-12-31) — Capital Expenditure: -4399000.00
BODI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -701000.00
BODI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1774000.00
BODI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1774000.00
BODI balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
BODI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
BODI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 38917000.00
BODI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 38917000.00
BODI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38917000.00
BODI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38917000.00
BODI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1030000.00
BODI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 519000.00
BODI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4399000.00
BODI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -701000.00
BODI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 21750000.00
BODI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4983000.00
BODI cash_flow (annual, 2025-12-31) — Change In Account Payable: -4191000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1043000.00
BODI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -6762000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -4918000.00
BODI cash_flow (annual, 2025-12-31) — Change In Inventory: 5402000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Inventory: 1503000.00
BODI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 22777000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1693000.00
BODI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -2733000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 2062000.00
BODI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -24003000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -6569000.00
BODI cash_flow (annual, 2025-12-31) — Change In Payable: -4191000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Payable: 1043000.00
BODI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -10953000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -3875000.00
BODI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2211000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2507000.00
BODI cash_flow (annual, 2025-12-31) — Change In Working Capital: -7299000.00
BODI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7693000.00
BODI cash_flow (annual, 2025-12-31) — Changes In Cash: 18381000.00
BODI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4801000.00
BODI balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
BODI balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
BODI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 31320000.00
BODI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 31320000.00
BODI income_statement (annual, 2025-12-31) — Cost Of Revenue: 67943000.00
BODI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 14188000.00
BODI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 12684000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 12684000.00
BODI balance_sheet (annual, 2025-12-31) — Current Assets: 63838000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Assets: 63838000.00
BODI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1036000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1036000.00
BODI balance_sheet (annual, 2025-12-31) — Current Debt: 1062000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Debt: 1062000.00
BODI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2098000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2098000.00
BODI balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 2016000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 2016000.00
BODI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 56866000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 56866000.00
BODI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 56866000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 56866000.00
BODI balance_sheet (annual, 2025-12-31) — Current Liabilities: 86596000.00
BODI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 86596000.00
BODI cash_flow (annual, 2025-12-31) — Depreciation: 8680000.00
BODI cash_flow (quarterly, 2025-12-31) — Depreciation: 1891000.00
BODI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 17554000.00
BODI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3820000.00
BODI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 17554000.00
BODI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3820000.00
BODI income_statement (annual, 2025-12-31) — Diluted Average Shares: 6971000.00
BODI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7366000.00
BODI income_statement (annual, 2025-12-31) — Diluted EPS: -0.41
BODI income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.71
BODI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5219000.00
BODI income_statement (annual, 2025-12-31) — EBIT: 2241000.00
BODI income_statement (quarterly, 2025-12-31) — EBIT: 6334000.00
BODI income_statement (annual, 2025-12-31) — EBITDA: 19795000.00
BODI income_statement (quarterly, 2025-12-31) — EBITDA: 10154000.00
BODI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 449000.00
BODI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 267000.00
BODI cash_flow (annual, 2025-12-31) — End Cash Position: 39017000.00
BODI cash_flow (quarterly, 2025-12-31) — End Cash Position: 39017000.00
BODI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1030000.00
BODI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 519000.00
BODI balance_sheet (annual, 2025-12-31) — Finished Goods: 4216000.00
BODI balance_sheet (quarterly, 2025-12-31) — Finished Goods: 4216000.00
BODI cash_flow (annual, 2025-12-31) — Free Cash Flow: 17351000.00
BODI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4282000.00
BODI cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 1980000.00
BODI cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 2087000.00
BODI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
BODI cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -1980000.00
BODI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2087000.00
BODI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -47000.00
BODI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -47000.00
BODI income_statement (annual, 2025-12-31) — General And Administrative Expense: 39907000.00
BODI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6540000.00
BODI balance_sheet (annual, 2025-12-31) — Goodwill: 65166000.00
BODI balance_sheet (quarterly, 2025-12-31) — Goodwill: 65166000.00
BODI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (annual, 2025-12-31) — Gross PPE: 122207000.00
BODI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 122207000.00
BODI income_statement (annual, 2025-12-31) — Gross Profit: 183784000.00
BODI income_statement (quarterly, 2025-12-31) — Gross Profit: 41348000.00
BODI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
BODI income_statement (annual, 2025-12-31) — Interest Expense: 4976000.00
BODI income_statement (quarterly, 2025-12-31) — Interest Expense: 1087000.00
BODI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 4976000.00
BODI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1087000.00
BODI balance_sheet (annual, 2025-12-31) — Inventory: 9410000.00
BODI balance_sheet (quarterly, 2025-12-31) — Inventory: 9410000.00
BODI balance_sheet (annual, 2025-12-31) — Invested Capital: 54946000.00
BODI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 54946000.00
BODI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4399000.00
BODI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -701000.00
BODI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 25000000.00
BODI cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
BODI balance_sheet (annual, 2025-12-31) — Leases: 20000.00
BODI balance_sheet (quarterly, 2025-12-31) — Leases: 20000.00
BODI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 738000.00
BODI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 738000.00
BODI balance_sheet (annual, 2025-12-31) — Long Term Debt: 22564000.00
BODI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 22564000.00
BODI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 23302000.00
BODI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 23302000.00
BODI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 25000000.00
BODI cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
BODI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -22582000.00
BODI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
BODI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 120562000.00
BODI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 120562000.00
BODI income_statement (annual, 2025-12-31) — Net Income: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5219000.00
BODI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -2860000.00
BODI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -2860000.00
BODI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5219000.00
BODI income_statement (annual, 2025-12-31) — Net Interest Income: -4976000.00
BODI income_statement (quarterly, 2025-12-31) — Net Interest Income: -1087000.00
BODI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2418000.00
BODI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BODI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2418000.00
BODI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BODI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4976000.00
BODI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1087000.00
BODI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2055000.00
BODI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3000.00
BODI balance_sheet (annual, 2025-12-31) — Net PPE: 10148000.00
BODI balance_sheet (quarterly, 2025-12-31) — Net PPE: 10148000.00
BODI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4399000.00
BODI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -701000.00
BODI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -33846000.00
BODI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -33846000.00
BODI balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 6292000.00
BODI balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 6292000.00
BODI income_statement (annual, 2025-12-31) — Normalized EBITDA: 26421000.00
BODI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 12241000.00
BODI income_statement (annual, 2025-12-31) — Normalized Income: 2374540.00
BODI income_statement (quarterly, 2025-12-31) — Normalized Income: 7294862.97
BODI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 21750000.00
BODI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4983000.00
BODI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 4146000.00
BODI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2087000.00
BODI income_statement (annual, 2025-12-31) — Operating Income: 8008000.00
BODI income_statement (quarterly, 2025-12-31) — Operating Income: 8180000.00
BODI income_statement (annual, 2025-12-31) — Operating Revenue: 251727000.00
BODI income_statement (quarterly, 2025-12-31) — Operating Revenue: 55536000.00
BODI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 7179724.00
BODI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 7179724.00
BODI balance_sheet (annual, 2025-12-31) — Other Current Assets: 1184000.00
BODI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1184000.00
BODI balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1062000.00
BODI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1062000.00
BODI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 3920000.00
BODI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3920000.00
BODI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -47000.00
BODI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -47000.00
BODI income_statement (annual, 2025-12-31) — Other Gand A: 39907000.00
BODI income_statement (quarterly, 2025-12-31) — Other Gand A: 6540000.00
BODI income_statement (annual, 2025-12-31) — Other Income Expense: -5767000.00
BODI income_statement (quarterly, 2025-12-31) — Other Income Expense: -1846000.00
BODI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3103000.00
BODI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 444000.00
BODI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1591000.00
BODI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1591000.00